Advent Technologies Holdings, Inc. ADN
We take great care to ensure that the data presented and summarized in this overview for ADVENT TECHNOLOGIES HOLDINGS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ADN
View all-
Vanguard Group Inc Valley Forge, PA1.27MShares$4.24 Million0.0% of portfolio
-
Prince Street Capital Management LLC New York, NY700KShares$2.35 Million5.32% of portfolio
-
Black Rock Inc. New York, NY555KShares$1.86 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA379KShares$1.27 Million0.0% of portfolio
-
Mirae Asset Global Investments Co., Ltd.356KShares$1.19 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny209KShares$700,1500.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA161KShares$538,3850.0% of portfolio
-
State Street Corp Boston, MA155KShares$519,9330.0% of portfolio
-
Morgan Stanley New York, NY118KShares$393,7950.0% of portfolio
-
Group One Trading, L.P. Chicago, IL111KShares$370,5300.0% of portfolio
Latest Institutional Activity in ADN
Top Purchases
Top Sells
About ADN
Advent Technologies Holdings, Inc., an advanced materials and technology development company, operates in the fuel cell and hydrogen technology markets. It develops, manufactures, and assembles fuel cell systems and critical components that determine the performance of hydrogen fuel cells and other energy systems. The company offers high-temperature proton exchange membrane (HT-PEM) fuel cells, HT-PEM based membrane electrode assemblies, membranes, and electrodes. It serves stationary and portable power, automotive, aviation, energy storage, and sensor markets. The company is headquartered in Boston, Massachusetts.
Insider Transactions at ADN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2024
|
Naiem Hussain Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
166,779
+39.85%
|
-
|
|
Sep 06
2023
|
Kevin L. Brackman CFO |
SELL
Open market or private sale
|
Direct |
27,771
-13.6%
|
$0
$0.53 P/Share
|
|
Sep 06
2023
|
Vassilios Gregoriou CEO, Chair |
SELL
Open market or private sale
|
Direct |
14,157
-0.22%
|
$0
$0.53 P/Share
|
|
Feb 04
2023
|
James F. Coffey COO, GC |
SELL
Payment of exercise price or tax liability
|
Direct |
29,046
-3.2%
|
$58,092
$2.04 P/Share
|
|
Feb 04
2023
|
Vassilios Gregoriou CEO, Chair |
SELL
Payment of exercise price or tax liability
|
Direct |
72,161
-1.1%
|
$144,322
$2.04 P/Share
|
|
Feb 04
2023
|
Emory Sayre De Castro CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
29,401
-1.2%
|
$58,802
$2.04 P/Share
|
|
Jan 12
2023
|
Panoraia Gourdoupi Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,688
+1.22%
|
-
|
|
Aug 31
2022
|
Panoraia Gourdoupi Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,688
-1.24%
|
-
|
|
Aug 24
2022
|
Kevin L. Brackman CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,281
-11.4%
|
$52,562
$2.84 P/Share
|
|
Jul 12
2022
|
Vassilios Gregoriou CEO, Chair |
BUY
Grant, award, or other acquisition
|
Direct |
175,000
+2.6%
|
-
|
|
Jun 15
2022
|
Lawrence Epstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
64,516
+48.83%
|
-
|
|
Jun 15
2022
|
Anggelos Skutaris Director |
BUY
Grant, award, or other acquisition
|
Direct |
64,516
+43.49%
|
-
|
|
Jun 15
2022
|
Wayne Threatt Director |
BUY
Grant, award, or other acquisition
|
Direct |
64,516
+50.0%
|
-
|
|
Feb 04
2022
|
Vassilios Gregoriou CEO, Chair |
SELL
Payment of exercise price or tax liability
|
Direct |
105,122
-1.6%
|
$420,488
$4.04 P/Share
|
|
Feb 04
2022
|
James F. Coffey COO, GC |
SELL
Payment of exercise price or tax liability
|
Direct |
28,639
-3.06%
|
$114,556
$4.04 P/Share
|
|
Feb 04
2022
|
Emory Sayre De Castro CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,454
-1.07%
|
$105,816
$4.04 P/Share
|
|
Aug 24
2021
|
Kevin L. Brackman CFO |
BUY
Grant, award, or other acquisition
|
Direct |
230,529
+50.0%
|
-
|
|
Jun 11
2021
|
Anggelos Skutaris Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,304
+41.67%
|
-
|
|
Jun 11
2021
|
Katherine E. Fleming |
BUY
Grant, award, or other acquisition
|
Direct |
19,304
+41.67%
|
-
|
|
Jun 11
2021
|
Christos Kaskavelis Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
345,794
+7.87%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 167K shares |
|---|
| Open market or private sale | 41.9K shares |
|---|